Market research
063160.KO CKD Bio Corp
KO KRW Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 70B
- P/E ratio
- Not available
- Analyst target
- 27000
- Dividend yield
- Not available
- Beta
- 0.59
Community
Investor discussion
1 comment
Sign in to join the 063160.KO discussion.
5 years, 6 months ago
CKD Bio Corp is currently in a long term downtrend where the price is trading 3.8% below its 200 day moving average.
From a valuation standpoint, the stock is 72.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.4.
CKD Bio Corp's total revenue sank by 29.4% to $27B since the same quarter in the previous year.
Its net income has dropped by 128.4% to $-987M since the same quarter in the previous year.
Finally, its free cash flow grew by 45.1% to $-6B since the same quarter in the previous year.
Based on the above factors, CKD Bio Corp gets an overall score of 2/5.